See also this year's filing and all EDGAR filings for this company.
PDF Report 0001722964_2021_Y_mAbs_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001722964, Y mAbs Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 122,363,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,825,000 |
| 3 | remainder_Assets | 7,859,000 |
| 4 | LiabilitiesCurrent | 19,535,000 |
| 5 | LiabilitiesNoncurrent | 3,981,000 |
| 6 | remainder_Liabilities | 2,695,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 44,785,000 |
| 9 | ResearchAndDevelopmentExpense | 93,697,000 |
| 10 | remainder_Expenses | 2,203,000 |
| 11 | remainder_Revenues | 20,750,000 |
| 12 | remainder_NetIncome | 598,000 |
| 13 | remainder_ComprehensiveNetIncome | -576,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 132,047,000 |
| 1 | Liabilities | 26,211,000 |
| 2 | Expenses | 140,685,000 |
| 3 | Revenues | 20,750,000 |
| 4 | StockholdersEquity | 105,836,000 |
| 5 | NetIncome | -119,337,000 |
| 6 | ComprehensiveNetIncome | -119,625,000 |
| 7 | BaseVar | 160,433,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.40 |
| 9 | EconomicCapitalRatio | 2.61 |
Edgar->Model Mapping
Feature Distribution
Change over Time
